相关实验视频

Updated: Sep 9, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

这是否是肝脏内胆血管癌的新时代?

Carolina Liguori¹, Andrea Benedetti Cacciaguerra², Riccardo Giampieri³

¹Medical Oncology Unit, Department of Molecular and Clinical Sciences, AOU delle Marche, Polytechnic University of Marche, Ancona, Italy; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

Critical reviews in oncology/hematology

|September 4, 2025

概括

肝脏内胆管癌 (iCCA) 的治疗因不同阶段而有所不同. 手术可以治愈切除的病例,而肝脏导向治疗和向治疗对于晚期或不可切除的肝内胆管癌至关重要.

科学领域:

肝胆道癌症
胃肠病学
癌症学

背景情况:

肝内胆管癌 (iCCA) 由于其独特特征而与其他胆管癌不同.
在少数 (~30%) 的iCCA患者中,手术切除可治愈.
先进的ICCA治疗领域正在发展到超越标准化疗.

研究的目的:

对所有疾病阶段的肝内胆管癌的当前治疗策略进行审查.
讨论新出现的治疗方法和iCCA管理的未来方向.
突出分子改变在指导iCCA治疗中的意义.

主要方法:

对iCCA治疗方式的综合文献审查.
对手术,肝脏治疗和全身治疗方案的分析.
基于分子分析的向治疗的探索.

主要成果:

手术是可切除iCCA的主要治疗方案.
肝脏导向治疗 (LDT) 和移植是肝脏疾病的选择.
化学免疫治疗是先进的iCCA的第一线治疗;针对性治疗越来越多地用于后期的可操作突变患者 (约40%).

结论:

肝内胆管癌的治疗需要多学科的方法.
个性化治疗策略,包括向治疗,对于改善结果至关重要.
持续的研究对于推进iCCA的治疗选择至关重要.

关键词:

其他国家美国地方地区的处理管理层进行手术系统性治疗针对性的治疗

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: